Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
1.680
+0.020 (1.20%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Nexalin Technology Revenue

In the year 2024, Nexalin Technology had annual revenue of $168.72K with 52.35% growth. Nexalin Technology had revenue of $27.18K in the quarter ending December 31, 2024, with 32.35% growth.

Revenue (ttm)
$168.72K
Revenue Growth
+52.35%
P/S Ratio
92.23
Revenue / Employee
$28,120
Employees
6
Market Cap
22.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024168.72K57.97K52.35%
Dec 31, 2023110.75K-1.21M-91.62%
Dec 31, 20221.32M1.18M817.20%
Dec 31, 2021144.07K-98.85K-40.69%
Dec 31, 2020242.91K35.53K17.13%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings